9072.5000 65.50 (0.73%)
NSE Dec 18, 2025 13:35 PM
Volume: 2,632
 

Business Standard
"Now that we've found what looks like a better efficacy we have to validate this, so we need to do an additional study," Soriot was quoted as saying
More from AstraZeneca Pharma India Ltd.
Recommended